From: Phenotypic diversity in an international Cure VCP Disease registry
Total participants (n = 22) | |
---|---|
Participant sex (M:F) | 10:12 |
Age at onset (n = 19)a | 43.4 ± 8.9 |
Age at diagnosis (n = 17)a | 49 ± 7.9 |
Age at participationa | 55.2 ± 9.9 |
Forced vital capacity, % predictedb (range) | 82 ± 25 (48–146) |
ALS-CBSb,c (range) | 17.1 ± 1.6 (14–20) |
Facial weakness | 11 (50%) |
Weakness of eye closure | 7 (32%) |
Weakness of lip closure | 9 (41%) |
Scapular winging | 12 (55%) |
Bilateral | 5 (23%) |
Unilateral | 7 (32%) |
IBM-FRSb,d (range) | 29.0 ± 7.0 (9–39) |
Timed up and go testb,e (n = 17, s, range) | 12.2 ± 6.0 (5.0–27.6) |
Walking aid | 14 (64%) |
Cane | 9 (41%)f |
Walker | 11(50%)g |
Wheelchair | 5 (23%)h |